Te Ahumairangi Investment Management Ltd decreased its holdings in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 9.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 42,645 shares of the company's stock after selling 4,710 shares during the period. Procter & Gamble makes up 1.3% of Te Ahumairangi Investment Management Ltd's holdings, making the stock its 23rd largest position. Te Ahumairangi Investment Management Ltd's holdings in Procter & Gamble were worth $7,344,000 as of its most recent SEC filing.
Other large investors also recently made changes to their positions in the company. International Assets Investment Management LLC increased its stake in Procter & Gamble by 19,030.8% in the third quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company's stock valued at $639,730,000 after purchasing an additional 3,674,286 shares in the last quarter. Wulff Hansen & CO. grew its holdings in shares of Procter & Gamble by 16,292.0% in the 2nd quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company's stock valued at $606,230,000 after buying an additional 3,653,477 shares during the period. Geode Capital Management LLC increased its position in shares of Procter & Gamble by 7.0% in the 3rd quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company's stock valued at $9,538,327,000 after buying an additional 3,619,466 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Procter & Gamble during the 3rd quarter worth $301,950,000. Finally, AMF Tjanstepension AB lifted its holdings in Procter & Gamble by 416.1% during the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company's stock worth $315,016,000 after acquiring an additional 1,466,115 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Stock Performance
PG stock traded up $0.22 during mid-day trading on Thursday, hitting $170.85. 4,023,040 shares of the company were exchanged, compared to its average volume of 6,698,313. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $180.43. The business has a 50 day simple moving average of $170.68 and a 200-day simple moving average of $169.50. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $402.36 billion, a PE ratio of 29.48, a price-to-earnings-growth ratio of 3.68 and a beta of 0.44.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company's revenue for the quarter was down .6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.83 EPS. On average, equities analysts forecast that The Procter & Gamble Company will post 6.97 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.36%. Procter & Gamble's dividend payout ratio is presently 69.31%.
Insider Activity at Procter & Gamble
In related news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the company's stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the sale, the insider now owns 11,566 shares of the company's stock, valued at $1,954,538.34. The trade was a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 83,080 shares of company stock worth $14,629,038. Company insiders own 0.18% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the company. DA Davidson raised Procter & Gamble from a "neutral" rating to a "buy" rating and raised their price target for the stock from $160.00 to $209.00 in a research report on Monday, November 25th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $164.00 price target on shares of Procter & Gamble in a research note on Monday, October 21st. Wells Fargo & Company increased their price objective on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an "overweight" rating in a research report on Friday, November 22nd. DZ Bank raised shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $190.00 target price for the company in a research note on Thursday, August 29th. Finally, Wolfe Research raised Procter & Gamble to a "strong-buy" rating in a research note on Friday, August 23rd. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $180.45.
View Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Company Profile
(
Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
